Mengdi Zhu

Yanjiang West Road 107#
Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

NFYA-Mediated TTK Up-Regulation Drives Fast Cell Cycle Progression and Its Inhibition Leads to Mitotic Catastrophe in Triple Negative Breast Cancer.

NFYA-Mediated TTK Up-Regulation Drives Fast Cell Cycle Progression and Its Inhibition Leads to Mitotic Catastrophe in Triple Negative Breast Cancer.

Journal: Cancers

Published: March 27, 2026

A Tumor-Agnostic, Topology-Informed Scoring Framework for Drug Repurposing: Application to CDK4/6 Inhibitor Resistance in HR+ Breast Cancer.

A Tumor-Agnostic, Topology-Informed Scoring Framework for Drug Repurposing: Application to CDK4/6 Inhibitor Resistance in HR+ Breast Cancer.

Journal: Biomedicines

Published: January 23, 2026

Everolimus destabilizes thymidylate synthase via suppressing its O-GlcNAcylation and sensitizes HER2-negative breast cancer to fluorouracil.

Everolimus destabilizes thymidylate synthase via suppressing its O-GlcNAcylation and sensitizes HER2-negative breast cancer to fluorouracil.

Journal: Cell death & disease

Published: December 12, 2025

3D-printed cell-free bioactive scaffolds from methacrylated hyaluronic acid and silk fibroin incorporating platelet-rich plasma for adipose tissue regeneration.

3D-printed cell-free bioactive scaffolds from methacrylated hyaluronic acid and silk fibroin incorporating platelet-rich plasma for adipose tissue regeneration.

Journal: International journal of biological macromolecules

Published: December 03, 2025

Construction and validation of acetylation-related gene signatures for immune landscape analysis and prognostication risk prediction in luminal breast cancer.

Construction and validation of acetylation-related gene signatures for immune landscape analysis and prognostication risk prediction in luminal breast cancer.

Journal: Cancer cell international

Published: February 16, 2025

circSCAP-encoded SCAP-129aa mediates platinum resistance in triple-negative breast cancer via the PI3K/AKT pathway.

circSCAP-encoded SCAP-129aa mediates platinum resistance in triple-negative breast cancer via the PI3K/AKT pathway.

Journal: Science China. Life sciences

Published: October 08, 2024

Different dosage forms of gonadotropin-releasing hormone agonist with endocrine therapy in premenopausal hormone receptor-positive breast cancer.

Different dosage forms of gonadotropin-releasing hormone agonist with endocrine therapy in premenopausal hormone receptor-positive breast cancer.

Journal: Journal of the National Cancer Institute

Published: February 07, 2024

LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein.

LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein.

Journal: Science advances

Published: October 06, 2023

SERPINA3-ANKRD11-HDAC3 pathway induced aromatase inhibitor resistance in breast cancer can be reversed by HDAC3 inhibition.

SERPINA3-ANKRD11-HDAC3 pathway induced aromatase inhibitor resistance in breast cancer can be reversed by HDAC3 inhibition.

Journal: Communications biology

Published: December 16, 2022

HDAC7 inhibits cell proliferation via NudCD1/GGH axis in triple-negative breast cancer.

HDAC7 inhibits cell proliferation via NudCD1/GGH axis in triple-negative breast cancer.

Journal: Oncology letters

Published: August 24, 2022

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors.

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors.

Journal: Science China. Life sciences

Published: May 07, 2022

LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer.

LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer.

Journal: Nature communications

Published: April 01, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026